Immunogenicity of poliovirus vaccines in chronically malnourished infants: A randomized controlled trial in Pakistan

被引:29
|
作者
Saleem, Ali Faisal [1 ]
Mach, Ondrej [2 ]
Quadri, Farheen [1 ]
Khan, Asia [1 ]
Bhatti, Zaid [1 ]
Rehman, Najeeb Ur [1 ]
Zaidi, Sohail [3 ]
Weldon, William C. [5 ]
Oberste, Steven M. [4 ]
Salama, Maha [6 ]
Sutter, Roland W. [2 ]
Zaidi, Anita K. M. [1 ]
机构
[1] Aga Khan Univ, Dept Pediat & Child Hlth, Karachi 74800, Pakistan
[2] WHO, Polio Eradicat Dept, CH-1211 Geneva, Switzerland
[3] Natl Inst Hlth, Dept Virol, Islamabad, Pakistan
[4] Ctr Dis Control & Prevent, Polio & Picornavirus Lab Branch, Atlanta, GA USA
[5] Ctr Dis Control & Prevent, Polio & Picornavirus Lab Branch, Populat Immun Lab, Atlanta, GA USA
[6] VACSERA Holding Co, Cairo, Egypt
关键词
Chronic malnutrition; Polio vaccine immunity; Seroconversion; Polio vaccine trial; EFFICACY; CHILDREN; ERADICATION; IMMUNITY; INDIA;
D O I
10.1016/j.vaccine.2015.04.055
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Reaching high population immunity against polioviruses (PV) is essential to achieving global polio eradication. Efficacy of oral poliovirus vaccine (OPV) varies and is lower among children living in tropical areas with impoverished environments. Malnutrition found as a risk factor for lower serological protection against PV. We compared whether inactivated polio vaccine (IPV) can be used to rapidly close the immunity gap among chronically malnourished (stunted) infants in Pakistan who will not be eligible for the 14 week IPV dose in routine EPI schedule. A phase 3, multicenter 4-arm randomized controlled trial conducted at five Primary Health Care (PHC) centers in Karachi, Pakistan. Infants, 9-12 months were stratified by length for age Z score into chronically malnourished and normally nourished. Infants were randomized to receive one dose of either bivalent OPV (bOPV) alone or bOPV + IPV. Baseline seroprevalence of PV antibodies and serum immune response to study vaccine dose were assessed by neutralization assay. Vaccine PV shedding in stool was evaluated 7 days after a bOPV challenge dose. Sera and stool were analyzed from 852/928(92%) enrolled children. At baseline, the seroprevalence was 85.6% (n=386), 73.6% (n = 332), and 70.7% (n=319) in malnourished children against PV types 1,2 and 3 respectively; and 94.1% (n = 448), 87.0% (n=441) and 83.6% (n=397) in the normally nourished group (p < 0.05). Children had previously received 9-10 doses of bOPV (80%) or tOPV (20%). One dose of IPV + bOPV given to malnourished children increased their serological protection (PVI, n = 201, 97.6%; PV2, n=198, 96.1% and PV3, n = 189, 91.7%) to parity with normally nourished children who had not received IPV (p = <0.001). Seroconversion and boosting for all three serotypes was significantly more frequent in children who received IPV + bOPV than in those with bOPV only (p <0.001) in both strata. Shedding of polioviruses in stool did not differ between study groups and ranged from 2.4% (n=5) to 7.1% (n=15). In malnourished children the shedding was reduced after bOPV + IPV compared to bOPV only. Chronically malnourished infants were more likely to be unprotected against polioviruses than normal infants. bOPV + IPV helped close the immunity gap better than bOPV alone. (C) 2015 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
引用
收藏
页码:2757 / 2763
页数:7
相关论文
共 50 条
  • [1] Immunogenicity of Different Routine Poliovirus Vaccination Schedules: A Randomized, Controlled Trial in Karachi, Pakistan
    Saleem, Ali F.
    Mach, Ondrej
    Yousafzai, Mohammad T.
    Khan, Asia
    Weldon, William C.
    Oberste, M. Steven
    Zaidi, Syed S.
    Alam, Muhammad M.
    Quadri, Farheen
    Sutter, Roland W.
    Zaidi, Anita K. M.
    [J]. JOURNAL OF INFECTIOUS DISEASES, 2018, 217 (03): : 443 - 450
  • [2] Safety and Immunogenicity of Malaria Vectored Vaccines Given with Routine Expanded Program on Immunization Vaccines in Gambian Infants and Neonates: A Randomized Controlled Trial
    Mensah, Victorine A.
    Roetynck, Sophie
    Kanteh, Ebrima K.
    Bowyer, Georgina
    Ndaw, Amy
    Oko, Francis
    Bliss, Carly M.
    Jagne, Ya Jankey
    Cortese, Riccardo
    Nicosia, Alfredo
    Roberts, Rachel
    D'Alessio, Flavia
    Leroy, Odile
    Faye, Babacar
    Kampmann, Beate
    Cisse, Badara
    Bojang, Kalifa
    Gerry, Stephen
    Viebig, Nicola K.
    Lawrie, Alison M.
    Clarke, Ed
    Imoukhuede, Egeruan B.
    Ewer, Katie J.
    Hill, Adrian V. S.
    Afolabi, Muhammed O.
    [J]. FRONTIERS IN IMMUNOLOGY, 2017, 8
  • [3] Effect of needle size on immunogenicity and reactogenicity of vaccines in infants: randomised controlled trial
    Diggle, Linda
    Deeks, Jonathan J.
    Pollard, Andrew J.
    [J]. BMJ-BRITISH MEDICAL JOURNAL, 2006, 333 (7568): : 571 - 574A
  • [4] Zinc supplementation fails to increase the immunogenicity of oral poliovirus vaccine: A randomized controlled trial
    Habib, M. A.
    Soofi, S.
    Sheraz, A.
    Bhatti, Z. S.
    Okayasu, H.
    Zaidi, S. Z.
    Molodecky, N. A.
    Pallansch, M. A.
    Sutter, R. W.
    Bhutta, Zulfigar A.
    [J]. VACCINE, 2015, 33 (06) : 819 - 825
  • [5] Immunogenicity of the Tuberculosis Vaccine MVA85A Is Reduced by Coadministration with EPI Vaccines in a Randomized Controlled Trial in Gambian Infants
    Ota, Martin O. C.
    Odutola, Aderonke A.
    Owiafe, Patrick K.
    Donkor, Simon
    Owolabi, Olumuyiwa A.
    Brittain, Nathaniel J.
    Williams, Nicola
    Rowland-Jones, Sarah
    Hill, Adrian V. S.
    Adegbola, Richard A.
    McShane, Helen
    [J]. SCIENCE TRANSLATIONAL MEDICINE, 2011, 3 (88)
  • [6] Immunogenicity of a tetravalent meningococcal glycoconjugate vaccine in infants - A randomized controlled trial
    Snape, Matthew D.
    Perrett, Kirsten P.
    Ford, Karen J.
    John, Tessa M.
    Pace, David
    Yu, Ly-Mee
    Langley, Joanne M.
    McNeil, Shelley
    Dull, Peter M.
    Ceddia, Francesca
    Anemona, Alessandra
    Halperin, Scott A.
    Dobson, Simon
    Pollard, Andrew J.
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2008, 299 (02): : 173 - 184
  • [7] Immunogenicity and safety of a combination pneumococcal-meningococcal in infants - A randomized controlled trial
    Buttery, JP
    Riddell, A
    MeVernon, J
    Chantler, T
    Lane, L
    Bowen-Morris, J
    Diggle, L
    Morris, R
    Harnden, A
    Lockhart, S
    Pollard, AI
    Cartwright, K
    Moxon, ER
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2005, 293 (14): : 1751 - 1758
  • [8] Evaluation of poliovirus type 2 outbreak response options: a randomized controlled trial, Karachi, Pakistan
    Yousafzai, M.
    Saleem, A. F.
    Mach, O.
    Weldon, W.
    Oberste, S.
    Alam, M.
    Quadri, F.
    Zaidi, A.
    [J]. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2018, 73 : 362 - 362
  • [9] Impact of Different Dosing Schedules on the Immunogenicity of the Human Rotavirus Vaccine in Infants in Pakistan: A Randomized Trial
    Ali, Syed Asad
    Kazi, Abdul Momin
    Cortese, Margaret M.
    Fleming, Jessica A.
    Parashar, Umesh D.
    Jiang, Baoming
    McNeal, Monica Malone
    Steele, Duncan
    Bhutta, Zulfiqar
    Zaidi, Anita
    [J]. JOURNAL OF INFECTIOUS DISEASES, 2014, 210 (11): : 1772 - 1779
  • [10] Combined immunization of infants with oral and inactivated poliovirus vaccines: Results of a randomized trial in the Gambia, Oman, and Thailand
    Greenwood, BM
    Hall, AJ
    Rowe, MG
    Whittle, HC
    George, M
    AlGhassani, AAK
    Elbualy, M
    Malankar, PG
    Suleiman, AJM
    Clements, GB
    Hay, ET
    Nairn, C
    Riding, MH
    Bell, E
    Hull, BP
    Robertson, SE
    Wright, PF
    Zoffmann, H
    Aree, C
    Samakoses, R
    Simasathien, S
    Migasena, S
    Pitisuttitham, P
    Ponrat, B
    Tantivanich, S
    Tharavanij, S
    Cochi, SL
    Linkins, RW
    Patriarca, PA
    Sutter, RW
    Anderson, L
    Maher, K
    Pallansch, M
    Penaranda, S
    [J]. BULLETIN OF THE WORLD HEALTH ORGANIZATION, 1996, 74 (03) : 253 - 268